GRACE MOSLEY: Open Payments
NPI 1699488775 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,051 in 45 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $320 · 2025 $1,051
Food & beverage: $1,051
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $164 |
| ABBVIE INC. | 7 | $145 |
| Novartis Pharmaceuticals Corporation | 4 | $114 |
| AstraZeneca Pharmaceuticals LP | 6 | $110 |
| Aimmune Therapeutics, Inc. | 3 | $60 |
| Lilly USA, LLC | 2 | $48 |
| PFIZER INC. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Novo Nordisk Inc | 2 | $36 |
| Amgen Inc. | 2 | $35 |
Products named: WATCHMAN FLX, LEQVIO, UBRELVY, QULIPTA, MOUNJARO, PREVNAR 20, FARXIGA, BREZTRI.
Industry payments across MO — which companies pay providers there.
